These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 28742409

  • 1. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Nasri K, Akrami S, Rahimi M, Taghizadeh M, Behfar M, Mazandaranian MR, Kheiry A, Memarzadeh MR, Asemi Z.
    Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
    [Abstract] [Full Text] [Related]

  • 2. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E, Samimi M, Ebrahimi FA, Foroozanfard F, Ahmadi S, Rahimi M, Jamilian M, Aghadavod E, Bahmani F, Taghizadeh M, Memarzadeh MR, Asemi Z.
    Mol Cell Endocrinol; 2017 Jan 05; 439():247-255. PubMed ID: 27619403
    [Abstract] [Full Text] [Related]

  • 3. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Foroozanfard F, Jamilian M, Bahmani F, Talaee R, Talaee N, Hashemi T, Nasri K, Asemi Z, Esmaillzadeh A.
    Clin Endocrinol (Oxf); 2015 Dec 05; 83(6):888-94. PubMed ID: 26119844
    [Abstract] [Full Text] [Related]

  • 4. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A.
    Clin Nutr; 2015 Aug 05; 34(4):586-92. PubMed ID: 25300649
    [Abstract] [Full Text] [Related]

  • 5. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Razavi M, Jamilian M, Karamali M, Bahmani F, Aghadavod E, Asemi Z.
    Horm Metab Res; 2016 Jul 05; 48(7):446-51. PubMed ID: 27050252
    [Abstract] [Full Text] [Related]

  • 6. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M, Jamilian M, Asemi Z.
    Biol Trace Elem Res; 2018 Mar 05; 182(1):21-28. PubMed ID: 28668998
    [Abstract] [Full Text] [Related]

  • 7. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M, Chamani M, Asemi Z.
    Horm Metab Res; 2017 Jul 05; 49(7):493-498. PubMed ID: 28679140
    [Abstract] [Full Text] [Related]

  • 8. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
    Jamilian M, Samimi M, Mirhosseini N, Afshar Ebrahimi F, Aghadavod E, Talaee R, Jafarnejad S, Hashemi Dizaji S, Asemi Z.
    J Affect Disord; 2018 Oct 01; 238():32-38. PubMed ID: 29859385
    [Abstract] [Full Text] [Related]

  • 9. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome.
    Karamali M, Ashrafi M, Razavi M, Jamilian M, Akbari M, Asemi Z.
    Exp Clin Endocrinol Diabetes; 2017 May 01; 125(5):316-321. PubMed ID: 28407660
    [Abstract] [Full Text] [Related]

  • 10. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M, Maktabi M, Asemi Z.
    Arch Iran Med; 2017 Oct 01; 20(10):640-645. PubMed ID: 29137465
    [Abstract] [Full Text] [Related]

  • 11. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
    Jamilian M, Foroozanfard F, Rahmani E, Talebi M, Bahmani F, Asemi Z.
    Nutrients; 2017 Nov 24; 9(12):. PubMed ID: 29186759
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR, Gargari BP, Farzadi L.
    Nutr Res; 2012 Mar 24; 32(3):195-201. PubMed ID: 22464806
    [Abstract] [Full Text] [Related]

  • 13. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T.
    Nutrients; 2019 Jan 17; 11(1):. PubMed ID: 30658483
    [Abstract] [Full Text] [Related]

  • 14. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M, Esfeh NK, Mohseni M, Karbassizadeh H, Asemi Z.
    Exp Clin Endocrinol Diabetes; 2018 Apr 17; 126(4):222-228. PubMed ID: 29117618
    [Abstract] [Full Text] [Related]

  • 15. Effects of Probiotic Supplementation on Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Karamali M, Eghbalpour S, Rajabi S, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M, Keneshlou F, Mirhashemi SM, Chamani M, Hashem Gelougerdi S, Asemi Z.
    Arch Iran Med; 2018 Jan 01; 21(1):1-7. PubMed ID: 29664663
    [Abstract] [Full Text] [Related]

  • 16. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Bahmani F, Karamali M, Shakeri H, Asemi Z.
    Clin Endocrinol (Oxf); 2014 Oct 01; 81(4):582-7. PubMed ID: 24628390
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.
    Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z.
    J Ovarian Res; 2019 Jan 21; 12(1):5. PubMed ID: 30665436
    [Abstract] [Full Text] [Related]

  • 18. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Foroozanfard F, Talebi M, Samimi M, Mehrabi S, Badehnoosh B, Jamilian M, Maktabi M, Asemi Z.
    Horm Metab Res; 2017 Aug 21; 49(8):612-617. PubMed ID: 28679142
    [Abstract] [Full Text] [Related]

  • 19. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M, Sabzevar NK, Asemi Z.
    Horm Metab Res; 2019 Feb 21; 51(2):100-105. PubMed ID: 30286483
    [Abstract] [Full Text] [Related]

  • 20. The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A.
    Biol Trace Elem Res; 2016 Jul 21; 172(1):72-78. PubMed ID: 26613790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.